Skip to main content
Supplement ScienceSupplementScience

Fish Oil Side Effects & Safety

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Safety Profile

Overall safety rating: Generally Safe

Potential Side Effects

  • Fishy burps and aftertaste — the most common complaint; reduced by enteric-coated capsules, triglyceride-form oil, refrigeration, or taking with meals
  • GI discomfort (nausea, diarrhea, bloating) — dose-dependent; start at 1g and increase gradually
  • Increased bleeding time — clinically insignificant at doses under 3g; relevant at high doses or with anticoagulants
  • Mild fishy body odor at high doses — uncommon but reported; may indicate oxidized (rancid) product
  • LDL cholesterol increase at very high doses — high-dose DHA (>2g) may modestly raise LDL in some individuals; EPA-only formulations avoid this

Drug & Supplement Interactions

  • Anticoagulants and antiplatelets (warfarin, aspirin, clopidogrel, heparin) — omega-3s have antiplatelet effects; additive bleeding risk at high doses
  • Antihypertensive medications — fish oil may lower blood pressure by 2-5 mmHg; monitor for additive hypotension
  • Orlistat — blocks fat absorption, reducing fish oil uptake; separate doses by 2+ hours
  • Statin medications — fish oil complements statins for triglyceride reduction (REDUCE-IT used fish oil + statin); no negative interaction
  • Cyclosporine — fish oil may alter cyclosporine levels; monitor in transplant patients

Maximum Dose

Do not exceed: 5g combined EPA+DHA/day (FDA considers up to 5g/day safe from supplements; prescription icosapent ethyl uses 4g/day under medical supervision)

Looking for a well-tested Fish Oil?
All our top picks are third-party verified for purity

References

  1. RCTBhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, Tardif JC, Ballantyne CM (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine. DOI PubMed
  2. Meta-analysisAbdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L (2020). Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. DOI PubMed
  3. Meta-analysisLiao Y, Xie B, Zhang H, He Q, Guo L, Subramanieapillai M, Fan B, Lu C, McIntyre RS (2019). Efficacy of omega-3 PUFAs in depression: a meta-analysis. Translational Psychiatry. DOI PubMed
  4. Meta-analysisMocking RJ, Harmsen I, Assies J, Koeter MW, Ruhe HG, Schene AH (2016). Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Translational Psychiatry. DOI PubMed
  5. Silveira JM, Ribeiro TS, Guilarducci MJ, Reis MG, et al. (2024). Effect of fish-oil supplementation on the glycemic and lipidemic profiles of pregnant women: a systematic review and meta-analysis.. Nutrition reviews. DOI PubMed
  6. Khoshnoudi-Nia S, Forghani Z, Jafari SM (2022). A systematic review and meta-analysis of fish oil encapsulation within different micro/nanocarriers.. Critical reviews in food science and nutrition. DOI PubMed
  7. Zhou J, Tang G, Tang S, Yuan W (2022). The effect of fish oil on inflammation markers in adult patients undergoing hemodialysis: A meta-analysis.. Seminars in dialysis. DOI PubMed
Show 1 more reference
  1. Kasawara KT, et al. (2024). The effect of Omega-3 supplementation and fish oil on preeclampsia: A systematic review and meta-analysis.. Prostaglandins, leukotrienes, and essential fatty acids. DOI PubMed